| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 19.366 | 65.330 | 81.690 | 74.362 | 74.296 | 97.325 |
| Total Income - EUR | - | - | - | - | 19.366 | 65.330 | 81.690 | 74.362 | 74.296 | 97.325 |
| Total Expenses - EUR | - | - | - | - | 5.692 | 45.544 | 58.281 | 37.978 | 45.054 | 45.755 |
| Gross Profit/Loss - EUR | - | - | - | - | 13.673 | 19.786 | 23.409 | 36.384 | 29.241 | 51.570 |
| Net Profit/Loss - EUR | - | - | - | - | 13.092 | 17.826 | 21.253 | 34.616 | 28.536 | 48.790 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ginlab Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 10.537 | 15.365 | 12.847 | 12.138 | 7.561 | 31.655 |
| Current Assets | - | - | - | - | 2.840 | 15.849 | 39.264 | 74.991 | 52.698 | 48.531 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 1.259 | 442 |
| Receivables | - | - | - | - | 0 | 12.151 | 0 | 0 | 4.829 | 14.036 |
| Cash | - | - | - | - | 2.840 | 3.698 | 39.264 | 74.991 | 46.609 | 34.054 |
| Shareholders Funds | - | - | - | - | 13.135 | 30.712 | 51.283 | 86.058 | 58.568 | 78.655 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 242 | 502 | 828 | 1.072 | 1.691 | 1.532 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginlab Health S.r.l.